Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited GLOSSARY `/INR ADR AGM AIDS ANDA API AS BPE BR BSE CAGR CDC CDP CDSL CEO CFO CGU CII CIN CIS CMV CoBE COO CPS CSIM CSR CTO DIN DMF DP DRF DRFHE EBITDA EPS ERM ESOP ETP EUG FTO FY GDP GDR GG GMP GSK HR Indian Rupees American Depository Receipt Annual General Meeting Acquired Immuno Deficiency Syndrome Abbreviated New Drug Application Active Pharmaceutical Ingredient Accounting Standards Business Process Excellence Business Responsibility Bombay Stock Exchange Compounded Annual Growth Rate United States Centers for Disease Control and Prevention Carbon Disclosure Project Central Depository Services (India) Limited Chief Executive Officer Chief Financial Officer Cash Generating Unit Confederation of Indian Industry Corporate Identity Number Commonwealth of Independent States Cytomegalovirus Code of Business Conduct and Ethics Chief Operating Officer Custom Pharmaceutical Services Centre for Social Initiative and Management Corporate Social Responsibility Chemical Technical Operations Director’s Identification Number Drug Master File Depository Participant Dr. Reddy’s Foundation Dr. Reddy’s Foundation for Health and Education Earnings Before Interest, Taxes, Depreciation and Amortization Earnings Per Share Enterprise-wide Risk Management Employees Stock Option Plan Effluent Treatment Plant Europe Generics Formulation Technical Operations Financial Year Gross Domestic Product Global Depository Receipt Global Generics Good Manufacturing Practices GlaxoSmithKline Human Resources IACC Indo American Chamber of Commerce ICAI Institute of Chartered Accountants of India IDMA Indian Drug Manufacturers Association IEPF Investor Education and Protection Fund IFRS International Financial Reporting Standards IGAAP Indian Generally Accepted Accounting Principles IMS IMS Health Inc. IP Intellectual Property IPA Indian Pharmaceutical Alliance IPDO Integrated Product Development Organisation IPO Initial Public Offer IT Information Technology KMP Key Managerial Personnel KPI Key Performance Indicator LABS Livelihood Advancement Business School M&A Mergers and Acquisitions MC Management Council MD Managing Director MD&A Management Discussion & Analysis NAG North America Generics NCEs New Chemical Entities NGO Non-Governmental Organisation NSDL National Securities Depository Limited NSE National Stock Exchange NYSE New York Stock Exchange OTC Over-the-counter PAT Profit After Tax PBT Profit Before Tax PP Proprietary Products PSAI Pharmaceuticals Services and Active Ingredients R&D Research and Development RoCE Return on Capital Employed RoW Rest of World SDF Sludge Disposal Facility SEBI Securities Exchange Board of India SEC Securities and Exchange Commission SEZ Special Economic Zone SG&A Selling, General and Administrative SMP Senior Management Personnel SOX Sarbanes Oxley Act, 2002 TPA Tonnes Per Annum UK United Kingdom US/USA United States of America USD/$ United States Dollar USFDA United States Food and Drugs Administration VUR Vesicoureteral Reflux 224
Notice Annual Report 2014 - 15 NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given that the 31st Annual General Meeting (AGM) of the members of Dr. Reddy’s Laboratories Limited (CIN: L85195TG1984PLC004507) will be held on Friday, 31 July 2015 at 9.30 AM at the Grand Ball Room, Hotel Taj Krishna, Road No. 1, Banjara Hills, Hyderabad – 500 034, to transact the following business: ORDINARY BUSINESS: 1. To receive, consider and adopt the financial statements of the Company for the year ended 31 March 2015, including the audited Balance Sheet as at 31 March 2015 and the Statement of Profit and Loss of the Company for the year ended on that date along with the reports of the Board of Directors and Auditors thereon. 2. To declare dividend on the equity shares for the financial year 2014-15. 3. To re-appoint Mr. G V Prasad (DIN: 00057433), who retires by rotation, and being eligible offers himself for the re-appointment. 4. To ratify the continuation of the Statutory Auditors. The Statutory Auditors M/s. B S R & Co. LLP, Chartered Accountants are eligible for continuing appointment. “RESOLVED THAT pursuant to the provisions of Section 139, 142 and other applicable provisions, if any, of the Companies Act, 2013 and their corresponding Rules, pursuant to the recommendations of the Audit Committee and the resolution passed by the members at their 30th AGM held on 31 July 2014, the appointment of M/s. B S R & Co. LLP, Chartered Accountants (ICAI Firm Registration No. 101248W/W- 100022), who have confirmed their eligibility in terms of the provisions of Section 141 of the Companies Act, 2013 and Rule 4 of Companies (Audit and Auditors) Rules, 2014, as Statutory Auditors to hold office up to the conclusion of the 32nd AGM, be and is hereby ratified at such remuneration as may be decided by the Board of Directors of the Company.” SPECIAL BUSINESS: 5. TO APPROVE THE REMUNERATION PAYABLE TO COST AUDITORS, M/S. SAGAR & ASSOCIATES FOR THE FINANCIAL YEAR ENDING 31 MARCH 2016. To consider and, if thought fit, to pass with or without modification(s) the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and all other applicable provisions of the Companies Act, 2013 and the Companies (Audit and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment thereof, for the time being in force), the Cost Auditors, M/s. Sagar & Associates, appointed by the Board of Directors of the Company, to conduct the audit of the cost records of the Company for the financial year ending 31 March 2016, be paid a remuneration of ` 6.00 lakhs (Rupees Six Lakhs) per annum plus out of pocket expenses, at actuals. RESOLVED FURTHER THAT the Board of Directors of the Company be and are hereby authorized to do all such acts, matters, deeds and things as may be necessary to give effect to the above resolution.” NOTES: 1. The statement pursuant to Section 102(1) of the Companies Act, 2013 in respect of the special business set out in the Notice, is annexed hereto. 2. A member entitled to attend and vote at the AGM is entitled to appoint a proxy to attend and vote instead of himself/herself and the proxy need not be a member of the Company. The instrument of proxy in order to be effective, must be deposited at the Registered Office of the Company, duly completed and signed, not less than 48 hours before the commencement of meeting. A person can act as a proxy on behalf of members not exceeding fifty and holding in the aggregate not more than ten percent of the total share capital of the Company carrying voting rights. A member holding more than ten percent of the total share capital of the Company carrying voting rights may appoint a single person as proxy and such person shall not act as a proxy for any other person or member. 3. Corporate members intending to send their authorised representatives to attend the Meeting are requested to send to the Company a certified copy of the Board Resolution authorizing their representative to attend and vote on their behalf at the Meeting. 4. During the period beginning 24 hours before the time fixed for the commencement of the meeting and ending with the conclusion of the meeting, a member would be entitled to inspect the proxies lodged with the Company, at any time during the business hours of the Company, provided that not less than three days of notice in writing is given to the Company. 5. The Register of Directors and Key Managerial Personnel and their shareholding, maintained under Section 170 of the Companies Act, 2013, will be available for inspection by the members at the AGM. 6. The Register of Contracts or Arrangements in which Directors are interested, maintained under Section 189 of the Companies Act, 2013, will be available for inspection by the members at the AGM. 7. The Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, 14 July 2015 to Friday, 17 July 2015 (both days inclusive). 8. The Board of Directors of the Company at their Meeting held on 12 May 2015 has recommended a dividend of ` 20 per share on equity share of ` 5/- each as final dividend for the financial year 2014-15. Dividend, if declared, at the Annual General Meeting, will be paid on or after 7 August 2015. 9. Pursuant to Clause 49 of the Listing Agreement with the Stock Exchanges, additional information including brief profile of Mr. G V Prasad who is proposed to be re-appointed by rotation, has been given in the section on Corporate Governance in this Annual Report. 10. The annual report for the financial year 2014-15 has been sent through email to those members who have opted to receive electronic communication or who have registered their email addresses with the Company/depository participants. The annual report is also available on our website, i.e. www.drreddys.com. The physical copy of the annual report has been sent to those members who have either opted for the same or have not registered their email addresses with the Company/depository participant. The members will be entitled to a physical copy of the annual report for the financial year 2014-15, free of cost, upon sending a request to the Company Secretary at 8-2-337, Road No. 3, Banjara Hills, Hyderabad – 500 034. 11. In case any member is desirous to receive communication from the Company in electronic form, they may register their email address 225
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176: Consolidated Financial Statements A
Page 225: Consolidated Financial Statements A
Page 229 and 230: E-Voting Annual Report 2014 - 15 IN
Page 231: Dr. Reddy’s Laboratories Limited
Page 235 and 236: The future belongs, not to those wh
show all

Good Health Can’t Wait.

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?